Literature DB >> 10677117

Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy.

G von Kobyletzki, A Uhle, C Pieck, K Hoffmann, P Altmeyer.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10677117     DOI： 10.1001/archderm.136.2.275

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.

Authors:  Frank Wang; Luis A Garza; Soyun Cho; Reza Kafi; Craig Hammerberg; Taihao Quan; Ted Hamilton; Maureen Mayes; Voravit Ratanatharathorn; John J Voorhees; Gary J Fisher; Sewon Kang
Journal:  Arch Dermatol       Date:  2008-07

Review 2.  UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.

Authors:  Frank Breuckmann; Thilo Gambichler; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-20

Review 3.  Ultraviolet A1 Phototherapy for Fibrosing Conditions.

Authors:  Thilo Gambichler; Lutz Schmitz
Journal:  Front Med (Lausanne)       Date:  2018-08-27

Review 4.  Emerging treatments for scleroderma/systemic sclerosis.

Authors:  Jane L Zhu; Samantha M Black; Henry W Chen; Heidi T Jacobe
Journal:  Fac Rev       Date:  2021-05-05

Review 5.  Phototherapy in Scleroderma.

Authors:  John Hassani; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.